Microgenics Corporation · Class II · Cleared Dec 21, 2022
| K-number | K213875 |
| Device name | DRI TM Tricyclics Serum Tox Assay |
| Applicant | Microgenics Corporation |
| Product code | LFH |
| Device class | Class II |
| Decision date | Dec 21, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 862.3910 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov